Business

Launch of D2C IBS Offering

Launch of D2C IBS Offering.

articleTrellus Health PlcFebruary 17, 20233/company/trellus-health-plc/news/launch-of-d2c-ibs-offering
Launch of D2C IBS Offering

About this update from Trellus Health Plc

[{"type":"text","content":"\n \n \n  \n \n \n \n Trellus Health plc\n \n \n \n (\"Trellus Health\" or the \"Company\")\n \n \n  \n \n \n \n Launch of D2C IBS Offering, Expansion of Mount Sinai Agreement\n \n \n \n \n and Related Party Transaction\n \n \n \n \n  \n \n \n \n \n Trellus now offering comprehensive Digestive Health solution\ncovering both IBD and IBS across both D2C and B2B2C channels\n \n \n \n \n  \n \n \n \n \n LONDON, U.K. AND NEW YORK, U.S. (17 February 2023):\n \n Trellus Health plc (AIM: TRLS), which is commercializing a scientifically validated, personalized resilience-driven self-management solution for chronic health conditions at their intersection with mental health, announces the launch of its Direct-to-Consumer (\"D2C\") offering for people living with Irritable Bowel Syndrome (\"IBS\").\n  \n The Company also announces the expansion of one of its existing agreements with the Mount Sinai Health System (\"Mount Sinai\"), under which the Trellus Resilience Training and Self-Management Solution (the \"Trellus Method\") is being made available as a wellness benefit to members of a large New York State labour union which provides health services and benefits to its members through Mount Sinai. This contract is now expanded to make the Trellus method available to people living with IBS as well as to patients with inflammatory bowel disease (\"IBD\"). The original contract with Mount Sinai was disclosed in regulatory announcements made on 17 October and 20 December 2022.\n  \n Trellus Health has now launched its D2C offering for IBS, providing its resilience-based methodology to support IBS patients' through coordinating and delivering personalized behavioural, emotional and nutritional support remotely via digital solutions, and provide access to an expert resilience team via telehealth. The D2C offering will also help to drive awareness and demand and further build an evidence base to support B2B2C engagement by providing real-world evidence of the health and economic outcomes of the Trellus Method and its application to chronic conditions.\n \n  \n \n The terms of the amended and restated Mount Sinai contract described above (the \"Contract\") are not materially changed, save for the expanded availability of the Trellus Method to members of the union with a diagnosis of IBS in addition to those memb...

More updates from Trellus Health Plc